The Clinical Implications of Graf Type IIA Hip Dysplasia

Description

In this presentation, Gregor Ramage, a final-year medical student at Cardiff University, discusses the clinical implications of diagnosing Graf type II hip dysplasia (DDH). He outlines the classification of DDH, emphasizing the importance of early detection and its association with successful non-surgical treatments, particularly for patients diagnosed with dysplastic hips. The presentation explores a ten-year study examining the clinical outcomes of patients with type IIA hip dysplasia, looking specifically at treatment rates and predictors of disease progression. Ramage highlights a significant difference in treatment percentages between IIA positive and IIA negative cases, noting that IIA negative hips require active management. He argues for the critical role of distinguishing between the two types to prevent overtreatment and ensure timely intervention for those at risk. The conclusion stresses the necessity of early follow-ups for patients with anatomical abnormalities or IIA negative hip dysplasia to enhance treatment outcomes.

Specialties